Literature DB >> 11010621

Regulations on statements made for dietary supplements concerning the effect of the product on the structure or function of the body. Food and Drug Administration, HHS. Final rule.

.   

Abstract

The Food and Drug Administration (FDA) is issuing final regulations defining the types of statements that can be made concerning the effect of a dietary supplement on the structure or function of the body. The regulations also establish criteria for determining when a statement about a dietary supplement is a claim to diagnose, cure, mitigate, treat, or prevent disease. This action is intended to clarify the types of claims that may be made for dietary supplements without prior review by FDA and the types of claims that require prior authorization as health claims or prior approval as drug claims.

Mesh:

Substances:

Year:  2000        PMID: 11010621

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  6 in total

Review 1.  The Basis of Structure/Function Claims of Nutraceuticals.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

2.  Perspective: Structure-Function Claims on Infant Formula.

Authors:  John C Wallingford
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

3.  Promoting Healthy Growth or Feeding Obesity? The Need for Evidence-Based Oversight of Infant Nutritional Supplement Claims.

Authors:  Michelle Lampl; Amanda Mummert; Meriah Schoen
Journal:  Healthcare (Basel)       Date:  2016-11-12

Review 4.  A Critical Review to Identify the Domains Used to Measure the Effect and Outcome of Adaptogenic Herbal Medicines.

Authors:  Sophia E Gerontakos; David Casteleijn; Alexander N Shikov; Jon Wardle
Journal:  Yale J Biol Med       Date:  2020-06-29

5.  Analysis of Select Dietary Supplement Products Marketed to Support or Boost the Immune System.

Authors:  Cindy Crawford; Bharathi Avula; Andrea T Lindsey; Abraham Walter; Kumar Katragunta; Ikhlas A Khan; Patricia A Deuster
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Regulatory oversight and safety of probiotic use.

Authors:  Veena Venugopalan; Kimberly A Shriner; Annie Wong-Beringer
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.